Meetings

Meeting Announcements

19-Apr-2026
 

Dana-Farber Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies

Dana-Farber Cancer Institute
Meeting Announcement
19-Apr-2026
 

NYU Langone Health neurologists present latest clinical findings and research at AAN 2026

NYU Langone Health / NYU Grossman School of Medicine
Meeting Announcement
17-Apr-2026
 

Dana-Farber researchers to present more than 50 research studies at American Association for Cancer Research Annual Meeting 2026

Dana-Farber Cancer Institute
Meeting Announcement
17-Apr-2026
 

Fiber optic cable captures minute slip events deep within Taiwan landslide

Seismological Society of America
Meeting Announcement